(-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels
- PMID: 25707820
- PMCID: PMC7116557
- DOI: 10.1002/anie.201411511
(-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels
Abstract
Current therapies for common types of cancer such as renal cell cancer are often ineffective and unspecific, and novel pharmacological targets and approaches are in high demand. Here we show the unexpected possibility for the rapid and selective killing of renal cancer cells through activation of calcium-permeable nonselective transient receptor potential canonical (TRPC) calcium channels by the sesquiterpene (-)-englerin A. This compound was found to be a highly efficient, fast-acting, potent, selective, and direct stimulator of TRPC4 and TRPC5 channels. TRPC4/5 activation through a high-affinity extracellular (-)-englerin A binding site may open up novel opportunities for drug discovery aimed at renal cancer.
Keywords: antitumor agents; calcium ions; ion channels; natural products.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figures
References
-
- Koehn FE, Carter GT. Nat Rev Drug Discovery. 2005;4:206–220. - PubMed
- Wilson RM, Danishefsky SJ. J Org Chem. 2006;71:8329–8351. - PubMed
- Kaiser M, Wetzel S, Kumar K, Waldmann H. Cell Mol Life Sci CMLS. 2008;65:1186–1201. - PMC - PubMed
- Bon RS, Waldmann H. Acc Chem Res. 2010;43:1103–1114. - PubMed
- Wetzel S, Bon RS, Kumar K, Waldmann H. Angew Chem. 2011;123:10900–11018. - PubMed
- Newman DJ, Cragg GM. J Nat Prod. 2012;75:311–335. - PMC - PubMed
- van Hattum H, Waldmann H. J Am Chem Soc. 2014;136:11853–11859. - PubMed
- Tao L, Zhu F, Qin C, Zhang C, Xu F, Tan CY, Jiang YY, Chen YZ. Nat Biotechnol. 2014;32:979–980. - PubMed
-
- Bioactivity of (-)Englerin A and analogues
- Ratnayake R, Covell D, Ransom TT, Gustafson KR, Beutler JA. Org Lett. 2009;11:57–60. - PMC - PubMed
- Radtke L, Willot M, Sun HY, Ziegler S, Sauerland S, Strohmann C, Frohlich R, Habenberger P, Waldmann H, Christmann M. Angew Chem. 2011;123:4084. Angew. Chem. Int. Ed. 2011, 50, 3998-4002. - PubMed
- Sulzmaier FJ, Li ZW, Nakashige ML, Fash DM, Chain WJ, Ramos JW. PLoS One. 2012;7 - PMC - PubMed
- Sourbier C, Scroggins BT, Ratnayake R, Prince TL, Lee S, Lee MJ, Nagy PL, Lee YH, Trepel JB, Beutler JA, et al. Cancer Cell. 2013;23:228–237. - PMC - PubMed
- Williams RT, Yu AL, Diccianni MB, Theodorakis EA, Batova A. J Exp Clin Cancer Res. 2013;32 For further studies concerning the bioactivity of Englerin A see ref. 5g. - PMC - PubMed
-
- Total syntheses of (-)Englerin A
- Willot M, Radtke L, Konning D, Frohlich R, Gessner VH, Strohmann C, Christmann M. Angew Chem. 2009;121:9269–9272. Angew. Chem. Int. Ed. 2009, 48, 9105-9108. - PubMed
- Molawi K, Delpont N, Echavarren AM. Angew Chem. 2010;122:3595–3597. Angew. Chem. Int. Ed. 2010, 49, 3517-3519. - PubMed
- Nicolaou KC, Kang QA, Ng SY, Chen DYK. J Am Chem Soc. 2010;132:8219–8222. - PubMed
- Xu J, Caro-Diaz EJE, Theodorakis EA. Org Lett. 2010;12:3708–3711. - PMC - PubMed
- Zhou QH, Chen XF, Ma DW. Angew Chem. 2010;122:3591–3594. Angew. Chem. Int. Ed. 2010, 49, 3513-3516.
- Li ZW, Nakashige M, Chain WJ. J Am Chem Soc. 2011;133:6553–6556. - PubMed
- Pouwer RH, Richard JA, Tseng CC, Chen DYK. Chem Asian J. 2012;7:22–35. - PubMed
- Zahel M, Kessberg A, Metz P. Angew Chem. 2013;125:5500–5502. Angew. Chem. Int. Ed. 2013, 52, 5390-5392. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
